The drug donanemab slows progression of symptoms in people with early stages of Alzheimer’s disease, but questions linger about the durability of its effect
has won unanimous approval from independent scientists advising the US Food and Drug Administration , bringing the treatment a step closer to use in the clinic., would be the second on the US market to slow the cognitive decline caused by the disease. But donanemab’s effects are modest, it does not reverse symptoms and the FDA might limit who can take it.
That an advisory meeting was called at all came as a surprise to many observers, who had expected the FDA to quickly approve donanemab without convening an advisory committee. Instead, the FDA delayed its decision until after the public meeting could be held because of questions about the drug’s efficacy in people with certain markers of Alzheimer’s disease.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Salt Lake man previously arrested in big drug bust faces new drug chargesA Salt Lake man arrested several years ago during a big drug bust in Cottonwood Heights is facing new charges of operating a drug lab.
Read more »
Make it Rain: How Repatriating Your Public Cloud Workload Can Save You MillionsA high performance, cloud-native object store offers you economic benefits, performance benefits, control benefits - and they compound with scale.
Read more »
Pharmacists cite highest number of drug shortages since 2001The Drug Information Service’s definition of a drug shortage is broader than the one used by the Food and Drug Administration.
Read more »
GBP/USD posts modest gains above 1.2650, focus on the FedspeakThe GBP/USD pair posts modest gains near 1.2670 during the early Asian session on Friday.
Read more »
Earnings call: Teknova sees modest revenue growth in Q1 2024Earnings call: Teknova sees modest revenue growth in Q1 2024
Read more »
‘IF’ Global Box Office Dreams of Success With Modest DebutThe giant purple imaginary friend from IF
Read more »